BOT 4.17% 34.5¢ botanix pharmaceuticals ltd

Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-372

  1. 1,221 Posts.
    lightbulb Created with Sketch. 695
    Vince Ippolito discusses everything about the Phase 2 trial for 20 minutes HERE (I copied it from the 'Well worth a listen!' thread). He is unable to offer anything substantial regarding the USA 'vehicle' anomaly, putting it down to the first time nature of producing a suitable Permetrex vehicle for the US trial (compared to the experienced Australian trial set-up). My opinion only, but he does not seem too concerned that it will affect FDA approval for Phase 3, stating that their US processes are now vastly improved from where they were at the beginning of the trial. It certainly increased my confidence as a holder.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
34.5¢
Change
-0.015(4.17%)
Mkt cap ! $624.4M
Open High Low Value Volume
36.0¢ 36.5¢ 34.0¢ $1.179M 3.382M

Buyers (Bids)

No. Vol. Price($)
2 101976 34.5¢
 

Sellers (Offers)

Price($) Vol. No.
35.0¢ 151653 1
View Market Depth
Last trade - 16.10pm 20/08/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.